Yoshinori Ishii1, Hideo Noguchi2, Junko Sato2, Tetsuya Sakurai2, Shin-Ichi Toyabe3. 1. Ishii Orthopaedic and Rehabilitation Clinic, 1089 Shimo-Oshi, Gyoda, Saitama, 361-0037, Japan. ishii@sakitama.or.jp. 2. Ishii Orthopaedic and Rehabilitation Clinic, 1089 Shimo-Oshi, Gyoda, Saitama, 361-0037, Japan. 3. Division of Information Science and Biostatistics, Niigata University Graduate School of Medical and Dental Sciences, 1 Asahimachi Dori Niigata, Niigata, 951-8520, Japan.
Abstract
PURPOSE: Whether the posterior cruciate ligament (PCL) should be retained or substituted in total knee arthroplasty (TKA) remains an issue of concern. The purpose of this study was to perform within-patient comparisons of mid- and long-term clinical outcomes after mobile-bearing TKA using PCL-retaining (PCLR) and PCL-substituting (PCLS) implant designs. METHODS: Clinical outcomes were assessed in thirty-eight patients (76 knees) who underwent bilateral scheduled staged TKA with a PCLR design on one side and a PCLS design on the other. Median follow-up periods were 118 months (range 60-211) and 114 months (62-198) in knees with PCLR and PCLS implants, respectively. The preoperative diagnosis for all patients was osteoarthritis. The postoperative clinical results of mobile-bearing TKAs using PCLR and PCLS implant designs were evaluated. RESULTS: The postoperative Hospital for Special Surgery and the new Knee Society Knee Scoring System scores revealed no differences between PCLR and PCLS implant designs. Postoperative flexion and extension also did not differ between designs. Postoperative median femorotibial alignment was 4° for PCLR and 5° for PCLS implants, respectively; this difference was not significant. Six of the knees with PCLR and three of the knees with PCLS implants had radiolucent lines around the tibial prostheses; these were less than 1 mm and nonprogressive. CONCLUSIONS: Clinically good results were obtained at approximately 10 years after mobile-bearing TKA using both PCLR and PCLS implant designs bilaterally in the same patients. These results provide conclusive evidence that equivalent clinical results can be obtained with either implant design. LEVEL OF EVIDENCE: Therapeutic study, Level II.
PURPOSE: Whether the posterior cruciate ligament (PCL) should be retained or substituted in total knee arthroplasty (TKA) remains an issue of concern. The purpose of this study was to perform within-patient comparisons of mid- and long-term clinical outcomes after mobile-bearing TKA using PCL-retaining (PCLR) and PCL-substituting (PCLS) implant designs. METHODS: Clinical outcomes were assessed in thirty-eight patients (76 knees) who underwent bilateral scheduled staged TKA with a PCLR design on one side and a PCLS design on the other. Median follow-up periods were 118 months (range 60-211) and 114 months (62-198) in knees with PCLR and PCLS implants, respectively. The preoperative diagnosis for all patients was osteoarthritis. The postoperative clinical results of mobile-bearing TKAs using PCLR and PCLS implant designs were evaluated. RESULTS: The postoperative Hospital for Special Surgery and the new Knee Society Knee Scoring System scores revealed no differences between PCLR and PCLS implant designs. Postoperative flexion and extension also did not differ between designs. Postoperative median femorotibial alignment was 4° for PCLR and 5° for PCLS implants, respectively; this difference was not significant. Six of the knees with PCLR and three of the knees with PCLS implants had radiolucent lines around the tibial prostheses; these were less than 1 mm and nonprogressive. CONCLUSIONS: Clinically good results were obtained at approximately 10 years after mobile-bearing TKA using both PCLR and PCLS implant designs bilaterally in the same patients. These results provide conclusive evidence that equivalent clinical results can be obtained with either implant design. LEVEL OF EVIDENCE: Therapeutic study, Level II.
Authors: Adam J Schwartz; Craig J Della Valle; Aaron G Rosenberg; Joshua J Jacobs; Richard A Berger; Jorge O Galante Journal: Clin Orthop Relat Res Date: 2010-05-04 Impact factor: 4.176
Authors: R Barry Sorrells; Paul E Voorhorst; Jeffrey A Murphy; Maryrose P Bauschka; A Seth Greenwald Journal: J Bone Joint Surg Am Date: 2004-10 Impact factor: 5.284
Authors: Taylor M Yong; Emily C Young; Ilda B Molloy; Brian M Fisher; Benjamin J Keeney; Wayne E Moschetti Journal: J Arthroplasty Date: 2019-08-14 Impact factor: 4.757
Authors: Liang Yuan; Bin Yang; Xiaohua Wang; Bin Sun; Ke Zhang; Yichen Yan; Jie Liu; Jie Yao Journal: Biomed Res Int Date: 2021-02-15 Impact factor: 3.411